Delivery Order SPE2DB25D3008-SPE2DB25FRDAV
- Not listed
- This delivery order, awarded August 22, 2025, to AmerisourceBergen Drug Corp represents a $4,719.34 firm fixed-price award for the supply of PREVYMIS 480 mg tablets (quantity 7) to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through December 2026. The contract involves no set-aside designation and was...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price Delivery Order by the Defense Logistics Agency (DLA) to provide PREVYMIS 480 MG TABLET 7S, a pharmaceutical product, with a potential value of $13,283.22. This Delivery Order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC allows...
- The Defense Logistics Agency awarded a $4.7K delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for PREVYMIS 480 mg tablets (7-count packaging). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,719.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of PREVYMIS 480 MG TABLET 7S. The contract, valued at $9,161.54, is a Firm Fixed Price Delivery Order with an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,438.70 fixed-price delivery order is for the supply of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a $17,710.96 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of PREVYMIS 480 MG TABLET 7S, a pharmaceutical product. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and...
- This federal contract award is a $4,719.34 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PREVYMIS 480 MG TABLET 7S, a medication, with a performance period extending through June 25, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prevymis 480 mg tablets (7-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $4.7K delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDAVDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for PREVYMIS 480 mg tablets (seven-count package) valued at $4,719.34 under a firm fixed-price arrangement. The award was issued on August 22, 2025, with an ultimate completion date of September 15, 2025. No set-aside designation was applied to this competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. The underlying contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. PREVYMIS, an antiviral medication, supports the DoD's medical supply chain requirements for military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 8/22/25 |